Prevention and adherence in Rheumatic and Musculoskeletal disease

Bente Appel Esbensen, Norelee Kennedy, Nina Brodin

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Rheumatic and Musculoskeletal Diseases (RMDs) are chronic conditions that affect a substantial number of people. RMDs are significantly related to co-morbidity. Therefore, focusing on prevention in RMDs is of importance to promote and maintain health. Prevention includes primary-, secondary-, tertiary-, and clinical prevention. Primary prevention aims to prevent the onset of disease before the disease process begins, secondary prevention includes detecting and reducing disease and risk factors at the earliest possible point, and tertiary prevention aims to limit the influence of a recognized or verified disease and to address or reduce further development or worsening of the disease, including physical and psychosocial disability. Clinical prevention attempts to integrate prevention into the disease management to limit disease progression and prevent complications and relapse. This chapter will focus on the evidence for prevention and highlight how innovations and trends can contribute by using digital technologies as an example.

    Original languageEnglish
    Article number101525
    Pages (from-to)101525
    JournalBest Practice and Research: Clinical Rheumatology
    Volume34
    Issue number2
    DOIs
    Publication statusPublished - Apr 2020

    Keywords

    • Adherence
    • Prevention
    • Self-management
    • Telehealth
    • eHealth

    Fingerprint

    Dive into the research topics of 'Prevention and adherence in Rheumatic and Musculoskeletal disease'. Together they form a unique fingerprint.

    Cite this